BTK and systemic lupus erythematosus: As we mentioned above, Fc receptor signaling overlaps with the signal transduction of the other two immunoreceptors at several aspects, therefore some of the therapies mentioned above (e.g. BTK inhibitors) may also contribute to the improvement of SLE symptoms through the inhibition of Fc receptor signaling.